Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.
A Chawla, G Murphy, C Donnelly, C L Booth, M Johnson, J V Parry, A Phillips, A M Geretti
Author Information
A Chawla: Department of Virology, Royal Free Hospital, Royal Free and University College Medical School, London, UK.
A guanidine-based antibody avidity assay for the identification of recently acquired human immunodeficiency virus type 1 (HIV-1) infection was evaluated. The kinetics of maturation of antibody avidity were determined prospectively in 23 persons undergoing acute seroconversion followed for up to 1,075 days. Avidity indices (AI) of
References
J Med Virol. 2000 Mar;60(3):324-30
[PMID: 10630965]